FDA Inspection 791930 — Anderson & Collins Clinical Research Inc.

Anderson & Collins Clinical Research Inc. — FEI 2246602

The FDA completed an inspection of Anderson & Collins Clinical Research Inc. on Jul 25, 2012 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jul 25, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Edison, NJ (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.